A Case of Biphasic Pulmonary Blastoma Treated with Carboplatin and Paclitaxel plus Bevacizumab
Clinical course showing decreased levels of AFP after the serial courses of chemotherapy with carboplatin and paclitaxel plus bevacizumab. After the recurrence, levels of AFP rapidly increased regardless of latter treatment with pemetrexed (PEM), docetaxel (DTX), and S-1 plus bevacizumab.
Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.